CRL
Charles River Laboratories International Earnings
$165.1
Earnings Summary
Revenue | $994.23Mn |
Net Profits | $-276.56Mn |
Net Profit Margins | -27.82% |
Charles River Laboratories International’s revenue fell -0.83% since last year same period to $994.23Mn in the Q4 2025. On a quarterly growth basis, Charles River Laboratories International has generated -1.06% fall in its revenue since last 3-months.
Charles River Laboratories International’s net profit fell -28.21% since last year same period to $-276.56Mn in the Q4 2025. On a quarterly growth basis, Charles River Laboratories International has generated -608.17% fall in its net profits since last 3-months.
Charles River Laboratories International’s net profit margin fell -29.29% since last year same period to -27.82% in the Q4 2025. On a quarterly growth basis, Charles River Laboratories International has generated -613.6% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 1.93 |
EPS Estimate Current Year | 1.93 |
Charles River Laboratories International’s earning per share (EPS) estimates for the current quarter stand at 1.93 - a -17.87% fall from last quarter’s estimates.
Charles River Laboratories International’s earning per share (EPS) estimates for the current year stand at 1.93.
Key Ratios
Earning Per Share (EPS) | 0 |
Charles River Laboratories International’s earning per share (EPS) fell -100% since last year same period to 0 in the Q1 2026. This indicates that the Charles River Laboratories International has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2026-05-07 | 1.93 | 0 | -100% |
